Business Description
Hyundai Pharmaceutical Co Ltd
ISIN : KR7004310009
Compare
Compare
Traded in other countries / regions
004310.Korea IPO Date
1978-06-28Description
Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.53 | |||||
| Debt-to-EBITDA | 7.57 | |||||
| Interest Coverage | 0.48 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.64 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.1 | |||||
| 3-Year EBITDA Growth Rate | 21.7 | |||||
| 3-Year EPS without NRI Growth Rate | 90.7 | |||||
| 3-Year Book Growth Rate | -0.6 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.02 | |||||
| 9-Day RSI | 40.35 | |||||
| 14-Day RSI | 39.3 | |||||
| 6-1 Month Momentum % | 5.14 | |||||
| 12-1 Month Momentum % | -1.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.45 | |||||
| Quick Ratio | 0.93 | |||||
| Cash Ratio | 0.14 | |||||
| Days Inventory | 109.8 | |||||
| Days Sales Outstanding | 79.03 | |||||
| Days Payable | 45.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.98 | |||||
| Dividend Payout Ratio | 1.84 | |||||
| Forward Dividend Yield % | 0.98 | |||||
| 5-Year Yield-on-Cost % | 0.98 | |||||
| 3-Year Average Share Buyback Ratio | 1.5 | |||||
| Shareholder Yield % | 1.89 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.72 | |||||
| Operating Margin % | 0.53 | |||||
| Net Margin % | 0.27 | |||||
| FCF Margin % | -7.83 | |||||
| ROE % | 0.56 | |||||
| ROA % | 0.3 | |||||
| ROIC % | 0.46 | |||||
| ROC (Joel Greenblatt) % | 2.94 | |||||
| ROCE % | 2.34 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 187.64 | |||||
| PS Ratio | 0.52 | |||||
| PB Ratio | 1.13 | |||||
| Price-to-Tangible-Book | 1.22 | |||||
| EV-to-EBIT | 58.02 | |||||
| EV-to-EBITDA | 22.43 | |||||
| EV-to-Revenue | 0.71 | |||||
| EV-to-FCF | -8.99 | |||||
| Price-to-Projected-FCF | 2.01 | |||||
| Price-to-Median-PS-Value | 0.54 | |||||
| Price-to-Net-Current-Asset-Value | 11.04 | |||||
| Earnings Yield (Greenblatt) % | 1.72 | |||||
| FCF Yield % | -15 | |||||
| Forward Rate of Return (Yacktman) % | 16.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hyundai Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 178,442.766 | ||
| EPS (TTM) (â‚©) | 19 | ||
| Beta | 0.65 | ||
| Volatility % | 59.12 | ||
| 14-Day RSI | 39.3 | ||
| 14-Day ATR (â‚©) | 192.193398 | ||
| 20-Day SMA (â‚©) | 3647 | ||
| 12-1 Month Momentum % | -1.52 | ||
| 52-Week Range (â‚©) | 3330 - 6620 | ||
| Shares Outstanding (Mil) | 26.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hyundai Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hyundai Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hyundai Pharmaceutical Co Ltd Frequently Asked Questions
What is Hyundai Pharmaceutical Co Ltd(XKRX:004310)'s stock price today?
The current price of XKRX:004310 is â‚©3565.00. The 52 week high of XKRX:004310 is â‚©6620.00 and 52 week low is â‚©3330.00.
When is next earnings date of Hyundai Pharmaceutical Co Ltd(XKRX:004310)?
The next earnings date of Hyundai Pharmaceutical Co Ltd(XKRX:004310) is .
Does Hyundai Pharmaceutical Co Ltd(XKRX:004310) pay dividends? If so, how much?
The Dividend Yield %  of Hyundai Pharmaceutical Co Ltd(XKRX:004310) is 0.98% (As of Today), Highest Dividend Payout Ratio of Hyundai Pharmaceutical Co Ltd(XKRX:004310) was 1.84. The lowest was 0.53. And the median was 0.7. The  Forward Dividend Yield % of Hyundai Pharmaceutical Co Ltd(XKRX:004310) is 0.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers